Find Paid Clinical Trials in Florida

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Florida

Top of Directory » All Locations » United States » Florida




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Treximet Early Intervention Adolescent Migraine

    Condition:   Adolescent Migraine
    Intervention:   Drug: Treximet
    Sponsors:   Premiere Research Institute;   GlaxoSmithKline
    Not yet recruiting - verified November 2009

  • Safety and Efficacy of a Glaucoma Drug Delivery System

    Conditions:   Open-Angle Glaucoma;   Ocular Hypertension
    Interventions:   Drug: bimatoprost;   Drug: bimatoprost;   Drug: Placebo
    Sponsor:   Vistakon Pharmaceuticals
    Recruiting - verified November 2009

  • Treatment of Androgenetic Alopecia in Females, 12 Beam

    Conditions:   Androgenetic Alopecia;   Hair Loss;   Female Pattern Baldness
    Interventions:   Device: HairMax LaserComb 2009 model 12 beam;   Device: Sham Device
    Sponsor:   Lexington International, LLC
    Not yet recruiting - verified November 2009

  • Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis

    Condition:   Ulcerative Proctitis
    Interventions:   Procedure: Proctosigmoidoscopy or colonoscopy with biopsy;   Procedure: Proctosigmoidoscopy;   Procedure: Blood collection;   Procedure: Electrocardiogram (ECG);   Drug: MAX-002;   Drug: Canasa®;   Drug: Placebo
    Sponsor:   Axcan Pharma
    Recruiting - verified November 2009

  • Clinical Evaluation of a Silicone Hydrogel Lens

    Condition:   Lotrafilcon A Contact Lens Use
    Intervention:  
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • A Trial to Evaluate the Safety and Immunogenicity of a Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) in Older Adults

    Condition:   Influenza
    Interventions:   Biological: Investigational Influenza VLP Vaccine 15ug/strain;   Biological: Investigational Influenza VLP Vaccine 60ug/strain;   Biological: TIV
    Sponsor:   Novavax
    Recruiting - verified November 2009

  • Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer

    Condition:   Pancreatic Cancer
    Interventions:   Procedure: Endoscopic Ultrasound (EUS);   Device: EUS/4D-ELF
    Sponsor:   Mayo Clinic
    Not yet recruiting - verified November 2009

  • An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease

    Condition:   Mild Alzheimer's Disease
    Interventions:   Drug: LNK-754;   Drug: Placebo
    Sponsor:   Link Medicine Corporation
    Recruiting - verified November 2009

  • Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

    Condition:   Adult ADHD
    Interventions:   Drug: AZD1446;   Drug: AZD1446;   Drug: AZD1446;   Drug: Placebo
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009

  • ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer

    Conditions:   Ovarian Cancer;   Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: ABT-888;   Drug: topotecan hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: MN-221 (Dose Group 1);   Drug: MN-221 (Dose Group 2);   Drug: MN-221 (Dose Group 3)
    Sponsor:   MediciNova
    Recruiting - verified November 2009

  • Study of Peer Relationships at School

    Condition:   Autism
    Intervention:   Behavioral: SKILLS vs ENGAGE
    Sponsors:   Health Resources and Services Administration (HRSA);   Florida State University;   Johns Hopkins University;   University of Michigan;   University of Washington
    Recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Correlation of Phonation With Deglutition and Aspiration Risk in the ICU Patients - an Exploratory Study

    Condition:   Deglutition and Aspiration Risk
    Intervention:   Other: (diadochokinesis, glottal coup, CAPE-V) and ordinal measures of swallowing function (MBS, FEES)
    Sponsor:   Mayo Clinic
    Recruiting - verified November 2009

  • A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

    Condition:   Melanoma
    Interventions:   Drug: YM155;   Drug: Docetaxel
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT) - A Pilot Study

    Condition:   Hematopoietic Stem Cell Transplantation
    Intervention:   Dietary Supplement: Lactobacillus plantarum strains 299 and 299v
    Sponsors:   Columbia University;   All Children's Hospital
    Not yet recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Study Evaluating the Efficacy and Safety of SBI-087 in Seropositive Subjects With Active Rheumatoid Arthritis

    Condition:   Active Rheumatoid Arthritis
    Intervention:   Drug: SBI-087
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.

    Condition:   Myelodysplastic Syndromes
    Interventions:   Drug: decitabine;   Drug: azacitidine
    Sponsor:   Eisai Inc.
    Not yet recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • South Florida Residents Knowledge and Opinions on End-of-Life Issues

    Condition:   Healthy
    Intervention:  
    Sponsor:   Nova Southeastern University
    Recruiting - verified September 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100/MART

    Condition:   Melanoma
    Interventions:   Drug: CP 870,893;   Biological: Peptides;   Biological: Oncovir poly IC:LC
    Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   National Cancer Institute (NCI);   Oncovir, Inc.
    Recruiting - verified November 2009

  • Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

    Conditions:   Bird Flu;   Influenza
    Interventions:   Other: Placebo;   Biological: Ad4-H5-Vtn
    Sponsor:   PaxVax, Inc.
    Recruiting - verified November 2009

  • Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment

    Conditions:   Traumatic Brain Injury;   Posttraumatic Stress Disorders;   Trauma;   Combat Disorders;   Pain
    Intervention:   Device: TMRDU
    Sponsors:   University of Illinois;   Department of Defense Telemedicine and Advanced Technology Research Center
    Not yet recruiting - verified November 2009

  • RSP® Prospective Multi-Center Study

    Conditions:   Rotator Cuff Deficiency;   Shoulder Arthropathy;   Failed Shoulder Replacement
    Intervention:   Device: Encore Reverse Shoulder Prosthesis (RSP®)
    Sponsor:   Encore Medical, L.P.
    Not yet recruiting - verified October 2009

  • A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

    Conditions:   Excessive Daytime Sleepiness;   Narcolepsy
    Interventions:   Drug: Placebo;   Drug: PF-03654746
    Sponsor:   Pfizer
    Recruiting - verified November 2009

  • Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

    Condition:   Brain and Central Nervous System Tumors
    Interventions:   Genetic: fluorescence in situ hybridization;   Genetic: loss of heterozygosity analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunohistochemistry staining method
    Sponsors:   North Central Cancer Treatment Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Tissue and Blood Samples From Patients With High-Grade Glioma

    Condition:   Brain and Central Nervous System Tumors
    Interventions:   Genetic: DNA ploidy analysis;   Genetic: fluorescence in situ hybridization;   Genetic: microsatellite instability analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: flow cytometry;   Other: immunohistochemistry staining method
    Sponsors:   North Central Cancer Treatment Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Leukemia
    Interventions:   Genetic: fluorescence in situ hybridization;   Genetic: mutation analysis;   Genetic: nucleic acid sequencing;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Other: flow cytometry;   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses

    Condition:   Pseudophakia
    Intervention:  
    Sponsor:   Innovative Medical
    Recruiting - verified October 2009

  • A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents

    Condition:   Acute Migraine With or Without Aura
    Intervention:   Drug: rizatriptan benzoate
    Sponsor:   Merck
    Recruiting - verified November 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

    Condition:   Metastatic Melanoma
    Interventions:   Procedure: Surgery;   Drug: Lymphodepletion
    Sponsor:   H. Lee Moffitt Cancer Center and Research Institute
    Recruiting - verified October 2009

  • A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents

    Condition:   Acute Migraine With or Without Aura in Children and Adolescents.
    Interventions:   Drug: rizatriptan benzoate;   Drug: Comparator: Placebo
    Sponsor:   Merck
    Recruiting - verified November 2009

  • Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)

    Conditions:   Graft-Versus-Host Disease;   Immune System Disorders
    Interventions:   Drug: Mycophenolate Mofetil;   Drug: Placebo
    Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Newtwork (BMT CTN)
    Not yet recruiting - verified October 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Not yet recruiting - verified November 2009

  • Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

    Condition:   Hypogonadism
    Intervention:   Drug: Testosterone gel 1.62%
    Sponsor:   Solvay Pharmaceuticals
    Recruiting - verified October 2009

  • EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

    Condition:   Leukemia-Lymphoma, Adult T-Cell
    Intervention:   Drug: Etoposide, Vincristine, Doxorubicin, Prednisone, Cyclophosphamide (EPOCH) with Bortezomib and Raltegravir
    Sponsor:   Washington University School of Medicine
    Not yet recruiting - verified October 2009

  • A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

    Condition:   Pregnancy Prevention
    Intervention:   Drug: DR-103
    Sponsor:   Teva Women's Health
    Recruiting - verified October 2009

  • TAXUS Libertē Post Approval Study

    Condition:   Coronary Artery Disease
    Interventions:   Device: TAXUS Liberté Paclitaxel-Eluting Coronary Stent;   Drug: prasugrel;   Drug: placebo;   Drug: aspirin
    Sponsors:   Boston Scientific Corporation;   Eli Lilly and Company;   Daiichi Sankyo Inc.
    Not yet recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials